We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+12.29%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.72B
AUM Growth
+$70.9M
Cap. Flow
-$118M
Cap. Flow %
-4.33%
Top 10 Hldgs %
18.23%
Holding
281
New
30
Increased
63
Reduced
134
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 19.64%
2 Technology 19.34%
3 Consumer Discretionary 15.99%
4 Industrials 14.25%
5 Financials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCOI icon
76
Cogent Communications
CCOI
$549M
$16.8M 0.62%
300,807
-9,890
-3% -$530K
ATRC icon
77
AtriCure
ATRC
$1.77B
$16.8M 0.62%
478,696
-19,890
-4% -$630K
COHR icon
78
Coherent
COHR
$54.3B
$16.7M 0.61%
352,613
-84,974
-19% -$3.86M
OCFC icon
79
OceanFirst Financial
OCFC
$1.73B
$16.3M 0.6%
597,043
-12,172
-2% -$356K
ATI icon
80
ATI
ATI
$25.4B
$16.1M 0.59%
544,796
-5,064
-0.9% -$136K
PS
81
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$16.1M 0.59%
502,899
+47,220
+10% +$1.39M
INSM icon
82
Insmed
INSM
$23.5B
$16M 0.59%
791,474
+72,585
+10% +$1.64M
OSUR icon
83
OraSure Technologies
OSUR
$266M
$15.1M 0.55%
975,514
-31,780
-3% -$521K
DRNA
84
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$14.8M 0.55%
972,622
+369,114
+61% +$5.37M
TPC
85
Tutor Perini Cor
TPC
$4.14B
$14.7M 0.54%
783,344
-26,756
-3% -$518K
ASMB icon
86
Assembly Biosciences
ASMB
$531M
$14.7M 0.54%
33,028
+13,579
+70% +$6.36M
USX
87
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$14.7M 0.54%
1,064,502
+53,002
+5% +$770K
TRHC
88
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$14.5M 0.53%
179,035
-186,463
-51% -$13.7M
JACK icon
89
Jack in the Box
JACK
$286M
$14.2M 0.52%
169,231
+32,910
+24% +$2.85M
TLYS icon
90
Tilly's
TLYS
$121M
$14M 0.51%
736,576
+94,800
+15% +$1.63M
GTT
91
DELISTED
GTT Communications, Inc.
GTT
$13.5M 0.5%
311,797
-330,970
-51% -$14.1M
AIMT
92
DELISTED
Aimmune Therapeutics
AIMT
$13.3M 0.49%
486,666
+36,230
+8% +$1.02M
ADMS
93
DELISTED
Adamas Pharmaceuticals
ADMS
$13.3M 0.49%
662,544
+22,610
+4% +$531K
URBN icon
94
Urban Outfitters
URBN
$6.25B
$13.1M 0.48%
320,176
+311,711
+3,682% +$14M
ILPT
95
Industrial Logistics Properties Trust
ILPT
$591M
$12.6M 0.46%
549,215
-17,430
-3% -$404K
XOG
96
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$12.4M 0.46%
1,101,612
-490,415
-31% -$6.23M
KPTI icon
97
Karyopharm Therapeutics
KPTI
$216M
$11.8M 0.43%
46,271
+8,850
+24% +$2.45M
SAIL
98
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$11.7M 0.43%
343,680
+128,680
+60% +$3.75M
CHUY
99
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$11.6M 0.43%
442,467
-6,810
-2% -$201K
CLVS
100
DELISTED
Clovis Oncology, Inc.
CLVS
$11.2M 0.41%
382,705
+27,672
+8% +$1.07M

Similar funds

Emerald Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Emerald Advisers held 281 positions worth $2.72B, up 2.7% from $2.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $118M in Q3 2018, closing 26 positions and reducing 134 holdings. Its most notable exit was Axos Financial, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Zogenix, Inc. worth $20.6M.

  • Emerald Advisers's largest Q3 2018 buy was Zogenix, Inc.: 415,100 shares worth $20.6M.
  • Emerald Advisers added most to Urban Outfitters in Q3 2018, an estimated $14M increase.
  • Emerald Advisers's biggest Q3 2018 reduction was FCB Financial Holdings, Inc., cutting an estimated $26.5M.
  • Emerald Advisers fully exited Axos Financial in Q3 2018, selling an estimated $29.2M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.72B portfolio in Q3 2018.
  • Emerald Advisers opened 30 new positions and closed 26 in Q3 2018.
  • Emerald Advisers's portfolio value rose 2.7% quarter-over-quarter to $2.72B.

Based on Emerald Advisers's 13F filing for Q3 2018, filed 31 Oct 2018.